{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:05:29Z","timestamp":1776395129864,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"crossref","award":["RIA2016E-1609"],"award-info":[{"award-number":["RIA2016E-1609"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian Ministry of Health"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijid.2019.01.039","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:36:22Z","timestamp":1548556582000},"page":"S62-S67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S","title":["Improving treatment outcomes for MDR-TB \u2014 Novel host-directed therapies and personalised medicine of the future"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0579-1097","authenticated-orcid":false,"given":"Martin","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-2979","authenticated-orcid":false,"given":"Giuseppe","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoki","family":"Mfinanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Ntoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1663-6287","authenticated-orcid":false,"given":"Dorothy","family":"Yeboah-Manu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2808-7270","authenticated-orcid":false,"given":"Cris","family":"Vilaplana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-5735","authenticated-orcid":false,"given":"Alimuddin","family":"Zumla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10163","key":"10.1016\/j.ijid.2019.01.039_bib0005","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(18)32340-7","article-title":"Learning from the youngsters: ixekizumab in active ankylosing spondylitis","volume":"392","author":"Baraliakos","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijid.2019.01.039_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/0074-02760170281","article-title":"Mycobacterium tuberculosis promotes genomic instability in macrophages","volume":"113","author":"Castro-Garza","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijid.2019.01.039_bib0015","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1038\/s41598-018-22061-x","article-title":"Next generation sequencing reveals changes of the \u03b3\u03b4 T cell receptor repertoires in patients with pulmonary tuberculosis","volume":"8","author":"Cheng","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ijid.2019.01.039_bib0020","article-title":"Adjunctive steroid therapy for managing pulmonary tuberculosis","author":"Critchley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.039_bib0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cid\/cix819","article-title":"Metformin use reverses the increased mortality associated with diabetes mellitus during tuberculosis treatment","volume":"66","author":"Degner","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2019.01.039_bib0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijid.2019.01.039_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2018.00257","article-title":"Functional and phenotypic changes of natural killer cells in whole blood during Mycobacterium tuberculosis infection and disease","volume":"9","author":"Garand","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ijid.2019.01.039_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007297","article-title":"Pathogen-based precision medicine for drug-resistant tuberculosis","volume":"14","author":"Gr\u00f6schel","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2019.01.039_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fmed.2018.00213","article-title":"Influence of genetic polymorphism towards pulmonary tuberculosis susceptibility","volume":"5","author":"Harishankar","year":"2018","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.01.039_bib0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/CMR.00096-15","article-title":"Microbiome changes during tuberculosis and antituberculous therapy","volume":"29","author":"Hong","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2019.01.039_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2018.02.006","article-title":"Meta-analysis of the lung microbiota in pulmonary tuberculosis","volume":"109","author":"Hong","year":"2018","journal-title":"Tuberculosis"},{"issue":"6","key":"10.1016\/j.ijid.2019.01.039_bib0060","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1168554","article-title":"Stereotaxic administrations of allogeneic human Vgamma9Vdelta2 T cells efficiently control the development of human glioblastoma brain tumors","volume":"5","author":"Jarry","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijid.2019.01.039_bib0065","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2017.00772","article-title":"Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review","volume":"8","author":"Kroesen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2019.01.039_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.ijid.2019.01.039_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.13304","article-title":"Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment","volume":"23","author":"Lange","year":"2018","journal-title":"Respirology"},{"issue":"10","key":"10.1016\/j.ijid.2019.01.039_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205807","article-title":"Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: a nationwide cohort study with validated diagnostic criteria","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijid.2019.01.039_bib0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3904\/kjim.2017.249","article-title":"The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus","volume":"33","author":"Lee","year":"2018","journal-title":"Korean J Intern Med"},{"issue":"6","key":"10.1016\/j.ijid.2019.01.039_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176354","article-title":"Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: comparisons of CT findings","volume":"12","author":"Li","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2019.01.039_bib0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/1462-2920.14015","article-title":"Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers","volume":"20","author":"Maji","year":"2018","journal-title":"Environ Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2019.01.039_bib0100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bjid.2017.01.001","article-title":"Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility","volume":"21","author":"Marupuru","year":"2017","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2019.01.039_bib0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2018\/4083921","article-title":"Mesenchymal stromal cells: from discovery to manufacturing and commercialization","volume":"2018","author":"Mizukami","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ijid.2019.01.039_bib0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fimmu.2018.00324","article-title":"Functional, antigen-specific stem cell memory (TSCM) CD4+ T cells are induced by human Mycobacterium tuberculosis infection","volume":"9","author":"Mpande","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2019.01.039_bib0115","series-title":"Improving treatment outcomes for patients with pulmonary tuberculosis in Tanzania: host and pathogen factors","author":"Nagu","year":"2017"},{"key":"10.1016\/j.ijid.2019.01.039_bib0120","series-title":"Oncoimmunology: a practical guide for cancer immunotherapy","first-page":"41","article-title":"Mutant epitopes in cancer","author":"Rao","year":"2018"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.039_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0884533612467824","article-title":"Drug-vitamin D interactions: a systematic review of the literature","volume":"28","author":"Robien","year":"2013","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"10.1016\/j.ijid.2019.01.039_bib0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.it.2018.11.003","article-title":"What, why, where, and when: bringing timing to immuno-oncology","volume":"40","author":"Rothschilds","year":"2019","journal-title":"Trends Immunol"},{"issue":"7720","key":"10.1016\/j.ijid.2019.01.039_bib0135","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","article-title":"A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes","volume":"560","author":"Roy Chowdhury","year":"2018","journal-title":"Nature"},{"issue":"263","key":"10.1016\/j.ijid.2019.01.039_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.ijid.2019.01.039_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046481","article-title":"Altered ratio of IFN-gamma\/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"7","author":"Skolimowska","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.039_bib0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2213-2600(13)70234-0","article-title":"Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial","volume":"2","author":"Skrahin","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"Suppl. 60","key":"10.1016\/j.ijid.2019.01.039_bib0155","article-title":"Potential role of autologous mesenchymal stromal cells in the treatment of multidrug and extensively drug-resistant tuberculosis","volume":"48","author":"Skrahin","year":"2016","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ijid.2019.01.039_bib0160","doi-asserted-by":"crossref","first-page":"e00014","DOI":"10.1128\/IAI.00014-18","article-title":"Identification and evaluation of novel protective antigens for the development of a candidate tuberculosis subunit vaccine","volume":"86","author":"Stylianou","year":"2018","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.ijid.2019.01.039_bib0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/heapol\/czy053","article-title":"Public\u2013private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya","volume":"33","author":"Suchman","year":"2018","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.ijid.2019.01.039_bib0170","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.12659\/MSM.904309","article-title":"Association of immune factors with drug-resistant tuberculosis: a case-control study","volume":"23","author":"Sun","year":"2017","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.ijid.2019.01.039_bib0175","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2019.01.039_bib0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3389\/fimmu.2017.00631","article-title":"The rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments","volume":"8","author":"Veluchamy","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2019.01.039_bib0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/qims.2018.03.06","article-title":"Radiological signs associated with pulmonary multi-drug resistant tuberculosis: an analysis of published evidences","volume":"8","author":"W\u00e1ng","year":"2018","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.ijid.2019.01.039_bib0190","series-title":"Global tuberculosis report 2018","author":"WHO","year":"2018"},{"issue":"10","key":"10.1016\/j.ijid.2019.01.039_bib0195","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1086\/598504","article-title":"Adalimumab treatment of life-threatening tuberculosis","volume":"48","author":"Wallis","year":"2009","journal-title":"Clini Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.01.039_bib0200","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw151","article-title":"Vitamin D as adjunctive host-directed therapy in tuberculosis: a systematic review","volume":"3","author":"Wallis","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.01.039_bib0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-016-0289-5","article-title":"Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials","volume":"23","author":"Wang","year":"2016","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1016\/j.ijid.2019.01.039_bib0210","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1038\/s41598-017-10346-6","article-title":"Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed","volume":"7","author":"Wipperman","year":"2017","journal-title":"Sci Rep"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T17:12:31Z","timestamp":1552065151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"alternative-id":["S1201971219300505"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.01.039","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving treatment outcomes for MDR-TB \u2014 Novel host-directed therapies and personalised medicine of the future","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}